Related Experiment Video
Updated: Jan 26, 2026

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Loc108167440 suppressed myeloma cell growth by P53-mediated apoptosis
Bing Zhai1,2, Chunmei Hou2, Ruonan Xu2,3
1Department of Geriatric Hematology, Chinese PLA General Hospital National Clinical Research Center for Geriatric Diseases , Beijing , China.
Abstract:
Multiple myeloma (MM) results from biased proliferation of cancerous plasma cells (PC). Therapeutic strategies that target MM PC will provide immense value to the treatment of MM. For this, it is necessary to identify novel molecules that differ between MM PC and healthy PC. RNA sequencing was used to determine differences in gene expression profiles between LPS-induced plasmablasts (PB)/PC and the PB-like myeloma SP 2/0 cell line. Compared to LPS-induced PB/PC, SP 2/0 cells expressed significantly lower levels of Loc108167440 mRNA. Loc108167440 overexpression reduced the number of SP 2/0 cells by stimulating apoptotic cell death. In addition, Loc108167440 overexpression suppressed tumor progression in the SP 2/0 xenograft mouse model. Finally, we demonstrated that Loc108167440 overexpression up-regulated expression of p53 in SP 2/0 cells. These results suggest that Loc108167440 overexpression suppressed SP 2/0 cell growth by inducing p53-mediated apoptosis. Thus, Loc108167440 overexpression may be a potential therapy for treating MM.
Insights
Overexpressing Loc108167440, a novel molecule, suppressed multiple myeloma (MM) cell growth and tumor progression by inducing p53-mediated apoptosis. This finding suggests Loc108167440 as a potential therapeutic target for MM.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Multiple myeloma (MM) is characterized by the uncontrolled proliferation of cancerous plasma cells (PC).
- Identifying novel molecular targets that distinguish MM PC from healthy PC is crucial for developing effective MM therapies.
- Current therapeutic strategies aim to specifically target and eliminate MM PC.
Purpose of the Study:
- To identify novel genes and molecules that are differentially expressed between MM PC and normal PC.
- To investigate the functional role of Loc108167440 in MM cell growth and tumor progression.
- To explore the potential of Loc108167440 as a therapeutic agent for multiple myeloma.
Main Methods:
- RNA sequencing was employed to compare gene expression profiles between LPS-induced plasmablasts/PC and the SP 2/0 myeloma cell line.
- Loc108167440 was overexpressed in SP 2/0 cells to assess its impact on cell viability and apoptosis.
- A xenograft mouse model was used to evaluate the effect of Loc108167440 overexpression on tumor progression.
- Western blotting or similar techniques were used to analyze p53 expression levels.
Main Results:
- SP 2/0 myeloma cells exhibited significantly lower levels of Loc108167440 mRNA compared to LPS-induced PB/PC.
- Overexpression of Loc108167440 led to a reduction in SP 2/0 cell number by inducing apoptotic cell death.
- Loc108167440 overexpression suppressed tumor growth in a xenograft mouse model of MM.
- Loc108167440 overexpression was found to up-regulate the expression of p53 in SP 2/0 cells.
Conclusions:
- Loc108167440 plays a significant role in suppressing the growth of multiple myeloma cells.
- The anti-myeloma effect of Loc108167440 is mediated through the induction of p53-dependent apoptosis.
- Loc108167440 represents a promising novel therapeutic target for the treatment of multiple myeloma.
Related Concept Videos
Apoptosis
Cells Coordinate Growth and Proliferation
Receptor-mediated Endocytosis
Population Growth
Cell-mediated Immune Responses
Meristems and Plant Growth

